The Centers for Disease and Control and Prevention (CDC) has given their support for giving a COVID-19 booster to children aged 12 to 15 years.
The US Food and Drug Administration recently expanded the emergency use authorization for COVID-19 Pfizer/BioNTech booster to include pediatric patients aged 12 years and older, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ recommendation to expand boosters to include children aged 12 to 15 years.1 The organization recommends that people aged 12 to 17 years receive a booster dose 5 months after undergoing the primary vaccine series.
In support of this expansion, CDC director, Rochelle Walensky, MD, MPH, said, “it is critical that we protect our children and teens from COVID-19 infection and the complications of severe disease. We now recommend that all adolescents aged 12-17 years should receive a booster shot 5 months after their primary series. This booster dose will provide optimized protection against COVID-19 and the Omicron variant. I encourage all parents to keep their children up to date with CDC’s COVID-19 vaccine recommendations.”
Reference
1. Centers for Disease Control and Prevention. CDC expands booster shot eligibility and strengthens recommendations for 12-17 year olds. Published January 5, 2022. Accessed January 10, 2022. https://www.cdc.gov/media/releases/2022/s0105-Booster-Shot.html
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years
April 9th 2024Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.